[1] Ligilactobacillus salivarius has been found to be of benefit in the alleviation of flatulence in individuals suffering from irritable bowel syndrome.
[2] Pancreatic necrosis, if left untreated, has an almost 100 percent fatality rate due to bacterial translocation[further explanation needed].
Ligilactobacillus salivarius has been found to have a wide spectrum of coverage against pathogenic organisms that translocate from the gastrointestinal tract thereby demonstrating therapeutic benefit in the management of pancreatic necrosis.
Research has shown that the addition of this species along with other probiotic species (specifically Bifidobacterium bifidum, Bifidobacterium infantis, Lactobacillus acidophilus, Lacticaseibacillus casei, and Lactococcus lactis) suppressed pro-inflammatory cytokines and further suppressed bacterial overgrowth in the small intestine leading to a reduction in bacterial translocation.
[4][5][6] L. salivarius has been shown in some studies to improve periodontal health by reducing bleeding on probing and inhibiting harmful bacteria.